Form 4: Cryoport CEO Jerrell Shelton Executes Stock Transactions Under 10b5-1 Plan
SEC Form 4
Cryoport's CEO, Jerrell Shelton, executed multiple stock option exercises and sales under a pre-arranged 10b5-1 trading plan.
Summary
- Cryoport CEO Jerrell Shelton exercised stock options and sold shares of common stock on November 21 and 22, 2024.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 15, 2024.
- On November 21, 2024, Mr. Shelton acquired 59,150 shares at $4.80 per share and sold 50,000 shares at a weighted average price of $6.5055.
- On November 22, 2024, he acquired 26,862 shares at $4.80 per share and sold 22,817 shares at a weighted average price of $6.4694.
- The sales on November 21 occurred at prices ranging from $6.31 to $6.66, and the sales on November 22 occurred at prices ranging from $6.34 to $6.60.
- Following these transactions, Mr. Shelton beneficially owns 735,942 shares of Cryoport common stock.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative for the company's overall outlook.
Industry Context
This is a routine filing related to insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the biotechnology and life sciences sectors, such as Thermo Fisher Scientific and Danaher Corporation.
- The vesting schedule of the stock options, with monthly vesting over a four-year period, is also a typical arrangement for executive compensation packages.
- The reported sale prices are within the range of recent trading activity for Cryoport stock, suggesting that the transactions were executed at market prices.
Stakeholder Impact
- The transactions may have a minor impact on the stock price due to the volume of shares sold by the CEO.
- The transactions do not have a direct impact on employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 2015-01-18 | Start date for the vesting of stock options, with 1/48th vesting each month. |
| 2024-03-15 | Date the 10b5-1 trading plan was adopted by Jerrell Shelton. |
| 2024-11-21 | Date of stock option exercise and sale of shares by Jerrell Shelton. |
| 2024-11-22 | Date of stock option exercise and sale of shares by Jerrell Shelton. |
| 2024-11-25 | Date of filing of the SEC Form 4. |
| 2024-12-18 | Expiration date of the stock options. |
Keywords
stock options, 10b5-1 trading plan, insider trading, stock sales, executive compensation, Cryoport, CYRX, Jerrell Shelton
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.